Austrian Pharmaceuticals & Biotech Potentially Undervalued Companies

Zoetis

Market Cap: €53.2b

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.

Cosmo Pharmaceuticals

Market Cap: €1.0b

Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.

Merck KGaA

Market Cap: €50.3b

Operates as a science and technology company in Germany and internationally.

Bayer

Market Cap: €27.5b

Operates as a life science company worldwide.

H. Lundbeck

Market Cap: €42.8b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

Marinomed Biotech

Market Cap: €36.7m

A biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally.

Novartis

Market Cap: €203.0b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Viatris

Market Cap: €12.3b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Bristol-Myers Squibb

Market Cap: €95.0b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Ipsen

Market Cap: €10.7b

Operates as a biopharmaceutical company worldwide.

H. Lundbeck

Market Cap: €42.8b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

Evotec

Market Cap: €926.1m

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

Johnson & Johnson

Market Cap: €472.1b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Pfizer

Market Cap: €142.5b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Biogen

Market Cap: €24.6b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Illumina

Market Cap: €18.4b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Regeneron Pharmaceuticals

Market Cap: €71.2b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Tecan Group

Market Cap: €1.8b

Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.

CureVac

Market Cap: €1.2b

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

Bavarian Nordic

Market Cap: €14.4b

Develops, manufactures, and supplies life-saving vaccines.

IQVIA Holdings

Market Cap: €37.6b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Merck

Market Cap: €230.6b

Operates as a healthcare company worldwide.

Valneva

Market Cap: €657.0m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Eurofins Scientific

Market Cap: €10.4b

Provides various analytical testing and laboratory services worldwide.

Sanofi

Market Cap: €109.4b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Takeda Pharmaceutical

Market Cap: €6.9t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.

Novo Nordisk

Market Cap: €1.4t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

Qiagen

Market Cap: €9.6b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Genmab

Market Cap: €121.6b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

BioMarin Pharmaceutical

Market Cap: €10.5b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Dermapharm Holding

Market Cap: €1.9b

Manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally.

Laboratorios Farmaceuticos Rovi

Market Cap: €3.0b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Grifols

Market Cap: €6.4b

Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.

Gilead Sciences

Market Cap: €155.1b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Tilray Brands

Market Cap: €1.2b

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally.

UCB

Market Cap: €43.4b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.